DGAP-Adhoc: CompuGroup Medical acquires EPSILOG
DGAP-Ad-hoc: CompuGroup Medical SE / Key word(s): Takeover
CompuGroup Medical acquires EPSILOG
27-Dec-2019 / 12:43 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
27 December 2019 - Koblenz, Germany, & Castries, France.
Today, CompuGroup Medical SE, as purchaser, and Hevanance S.à r.l. and Goodwill Systems S.à r.l., as sellers, have signed an agreement regarding the sale and purchase of 100 % of the shares in MB Invest SAS which is the sole owner of EPSILOG SAS (EPSILOG), based in Castries, France.
EPSILOG's key product is VEGA, an ambulatory information system with a leading position in French healthcare IT for nurses and physiotherapists.
The agreed purchase price for EPSILOG amounts to EUR 72m and is subject to further adjustments post-closing. In 2018, EPSILOG had revenues of more than EUR 14 million with an EBITDA of approximately EUR 5 million. EPSILOG's customer base today consists of more than 44,000 providers across the ambulatory market segment.
Closing of the transaction is expected for 27 December 2019.
For further information please refer to:
CompuGroup Medical SE
Investor Relations
Maria Trost 21
56070 Koblenz, Germany
Contact person:
Claudia Thomé
Head of Investor Relations
CompuGroup Medical SE
Email: claudia.thome@cgm.com
Tel +49 261 8000 7030
Tel +49 261 8000 6200
27-Dec-2019 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de
End of Announcement DGAP News Service
943855 27-Dec-2019 CET/CEST